methotrexat ebewe 100 mg/ml infuusiokonsentraatti, liuosta varten
ebewe pharma ges.m.b.h. nfg.kg - methotrexate - infuusiokonsentraatti, liuosta varten - 100 mg/ml - metotreksaatti
modulis vet 100 mg/ml oraaliliuos
ceva santÉ animale - ciclosporin - oraaliliuos - 100 mg/ml - siklosporiini
glinor 2.8 mg/annos nenäsumute, liuos
merckle gmbh - natrii cromoglicas - nenäsumute, liuos - 2.8 mg/annos - natriumkromoglikaatti
videx ec 125 mg enterokapseli, kova
bristol-myers squibb ab - didanosinum - enterokapseli, kova - 125 mg - didanosiini
videx ec 200 mg enterokapseli, kova
bristol-myers squibb ab - didanosinum - enterokapseli, kova - 200 mg - didanosiini
videx ec 250 mg enterokapseli, kova
bristol-myers squibb ab - didanosinum - enterokapseli, kova - 250 mg - didanosiini
videx ec 400 mg enterokapseli, kova
bristol-myers squibb ab - didanosinum - enterokapseli, kova - 400 mg - didanosiini
prostide 150 mg tabletti, kalvopäällysteinen
icn polfa rzeszów s.a. - bicalutamidum - tabletti, kalvopäällysteinen - 150 mg - bikalutamidi
epysqli
samsung bioepis nl b.v. - ekulitsumabi - hemoglobinuria, paroxysmal - immunosuppressantit - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.